Biohit Oyj - Managers' Transactions
Biohit Oyj - Managers' Transactions, April 10, 2017 at 12:30 pm local time (EEST)
Biohit Oyj has received the following notification.
Person subject to the notification requirement | ||
Name: | Euroclone Spa | Legal Person |
Position: | Closely associated person | |
Person discharging managerial responsibilities in issuer | ||
Name: | Aiolfi, Franco | |
Position: | Member of the Board/Deputy member | |
Initial Notification | ||
Reference number: | 74370089ATTSNBXJVT29_20170410113223_12 | |
Issuer | ||
Name: | Biohit Oyj | |
LEI: | 74370089ATTSNBXJVT29 | |
Transaction details | ||
Transaction date: | 2017-04-05 | |
Venue: | NASDAQ HELSINKI LTD (XHEL) | |
Nature of the transaction: | Disposal | |
Instrument: | Share | |
ISIN: | FI0009005482 | |
Volume: | 35 | |
Unit price: | 5,67000 Euro | |
Volume: | 79 | |
Unit price: | 5,50000 Euro | |
Volume: | 75 | |
Unit price: | 5,51000 Euro | |
Volume: | 406 | |
Unit price: | 5,50000 Euro | |
Volume: | 379 | |
Unit price: | 5,50000 Euro | |
Volume: | 905 | |
Unit price: | 5,52000 Euro | |
Volume: | 553 | |
Unit price: | 5,53000 Euro | |
Volume: | 2148 | |
Unit price: | 5,50000 Euro | |
Volume: | 742 | |
Unit price: | 5,50000 Euro | |
Volume: | 270 | |
Unit price: | 5,50000 Euro | |
Volume: | 28 | |
Unit price: | 5,50000 Euro | |
Volume: | 300 | |
Unit price: | 5,50000 Euro | |
Aggregated transactions | ||
Volume: | 5920 | |
Volume weighted average price: | 5.50699 Euro |
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com